CVS Health Corp (NYSE: CVS) is -43.82% lower on its value in year-to-date trading and has touched a low of $43.60 and a high of $83.25 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CVS stock was last observed hovering at around $43.78 in the last trading session, with the day’s gains setting it 0.58%.
Currently trading at $44.36, the stock is -17.19% and -21.03% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 21.08 million and changing 1.32% at the moment leaves the stock -27.05% off its SMA200. CVS registered -42.57% loss for a year compared to 6-month loss of -28.14%. The firm has a 50-day simple moving average (SMA 50) of $56.1704 and a 200-day simple moving average (SMA200) of $60.8123.
The stock witnessed a -21.94% gain in the last 1 month and extending the period to 3 months gives it a -22.95%, and is -10.15% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.44% over the week and 3.25% over the month.
CVS Health Corp (CVS) has around 300000 employees, a market worth around $56.56B and $369.15B in sales. Current P/E ratio is 11.27 and Fwd P/E is 7.30. Profit margin for the company is 1.36%. Distance from 52-week low is 1.74% and -46.71% from its 52-week high. The company has generated returns on investments over the last 12 months (3.34%).
with sales reaching $96.96B over the same period.The EPS is expected to shrink by -39.44% this year, but quarterly earnings will post 3.90% year-over-year. Quarterly sales are estimated to grow 3.35% in year-over-year returns.
CVS Health Corp (CVS) Top Institutional Holders
2389.0 institutions hold shares in CVS Health Corp (CVS), with institutional investors hold 82.93% of the company’s shares. The shares outstanding are 1.26B, and float is at 1.26B with Short Float at 1.42%. Institutions hold 82.82% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 116.35 million shares valued at $6.87 billion. The investor’s holdings represent 9.2341% of the CVS Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 100.15 million shares valued at $5.91 billion to account for 7.9485 of the shares outstanding. The other top investors are DODGE & COX which holds 61.68 million shares representing 4.8955% and valued at over $3.64 billion, while CAPITAL WORLD INVESTORS holds 4.4463 of the shares totaling 56.02 million with a market value of $3.31 billion.
CVS Health Corp (CVS) Insider Activity
The most recent transaction is an insider purchase by LUDWIG EDWARD J, the company’s Director. SEC filings show that LUDWIG EDWARD J bought 1,000 shares of the company’s common stock on May 02 ’24 at a price of $53.88 per share for a total of $53879.0. Following the purchase, the insider now owns 21630.0 shares.
CVS Health Corp disclosed in a document filed with the SEC on May 02 ’24 that Mahoney Michael F (Director) bought a total of 9,181 shares of the company’s common stock. The trade occurred on May 02 ’24 and was made at $54.49 per share for $0.5 million. Following the transaction, the insider now directly holds 9356.0 shares of the CVS stock.
Still, SEC filings show that on Feb 16 ’24, Shah Prem S (EVP and Pres-Pharm, Consumer W) disposed off 29,473 shares at an average price of $76.95 for $2.27 million. The insider now directly holds 39,765 shares of CVS Health Corp (CVS).
